Financial Performance - Total revenue for the six months ended June 30, 2024, was HK1,989,690,000,aslightdecreaseof0.31,996,136,000 in the same period last year[9]. - Gross profit increased to HK575,214,000,representinga30.4440,984,000 in the previous year[9]. - Profit for the period reached HK240,085,000,up129.4104,611,000 in the same period last year[9]. - Earnings per share for the period were HK29.1cents,comparedtoHK12.7 cents in the previous year, marking a significant increase[9]. - The company reported a profit before taxation of HK297,776,000,significantlyhigherthanHK130,510,000 in the previous year[9]. - Total comprehensive income for the period was HK240,368,000,whichincludesaprofitfortheperiodofHK240,085,000, reflecting stable performance compared to previous periods[15]. - Profit for the period attributable to owners of the Company was HK240,085,000,asignificantincreasefromHK104,611,000 in 2023, representing a growth of approximately 129%[45]. Revenue Breakdown - Revenue from the manufacture and sale of chemical products was HK1,968,854,comparedtoHK1,938,347 in the previous year, indicating an increase of about 1.6%[26]. - Revenue from chloromethane products decreased to HK457,431fromHK467,513, reflecting a decline of approximately 2.3%[26]. - The Group's revenue from contracts with customers was HK1,987,848,slightlydownfromHK1,996,136, a decrease of about 0.4%[26]. - The Group's rental income for the period was HK1,842,whichisanewrevenuestreamintroducedthisyear[26].−Thechemicalsegmentincludesthemanufactureandsaleofvariousproducts,withafocusonmaintainingoperationalefficiencyandprofitability[28].−Thepropertysegmentgeneratedrevenuefrompropertydevelopmentandsales,alongsiderentalincome,contributingtotheoverallfinancialperformance[28].CostManagement−ThecostofsalesdecreasedtoHK1,414,476,000, down 9.1% from HK1,555,152,000inthepreviousyear[9].−ResearchanddevelopmentcostswereHK54,529,000, a decrease from HK71,850,000inthepreviousyear,indicatingafocusoncostmanagement[9].−SellinganddistributionexpensesforthesixmonthsendedJune30,2024,wereapproximatelyHK108 million, a decrease of approximately HK1millionfromHK109 million in the previous period, representing about 5.4% of total revenue[92]. - General and administrative expenses increased to approximately HK135million,upHK7 million from HK128millioninthepreviousperiod,representingapproximately6.813 million, a decrease of approximately HK9millionfromHK22 million in the previous period due to reduced outstanding loan balances[95]. Asset and Liability Management - As of June 30, 2024, total assets less current liabilities amounted to HK5,990,018,anincreasefromHK5,857,151 as of December 31, 2023, reflecting a growth of approximately 2.26%[11]. - The company's total equity as of June 30, 2024, was HK5,924,623,upfromHK5,799,755 at the end of 2023, representing an increase of approximately 2.15%[11]. - Current liabilities increased to HK1,137,548fromHK1,171,816, showing a decrease of about 2.92%[10]. - Bank borrowings decreased significantly to HK491,209fromHK671,767, a reduction of approximately 26.8%[10]. - The net debt to equity ratio as of June 30, 2024, was 4.77%, down from 7.04% as of December 31, 2023, reflecting improved financial stability[103]. Cash Flow and Investments - For the six months ended June 30, 2024, net cash from operating activities was HK606,222,000,asignificantincreasefromHK271,082,000 in the same period of 2023, representing a growth of approximately 124%[16]. - The company reported a net cash used in investing activities of HK351,096,000forthesixmonthsendedJune30,2024,comparedtoHK332,307,000 in the prior year, indicating a slight increase of about 5.2%[16]. - Payments for the purchase of property, plant, and equipment amounted to HK295,666,000,comparedtoHK127,222,000 in the previous year, indicating a significant increase in capital expenditures[16]. - The Group spent approximately HK485milliononproperty,plant,andequipmenttoexpanditsoperationsduringtheperiod[51].FutureOutlookandStrategicInitiatives−Thecompanycontinuestoexploremarketexpansionopportunitiesandnewproductdevelopmentstrategies[8].−Futureoutlookremainspositivewithongoinginvestmentsintechnologyandpotentialacquisitionstoenhancemarketposition[8].−TheGroupplanstoenhanceproductionautomationacrossitsthreefactoriestoimprovecost−effectivenessandproductionefficiency[80].−Newproductionlinesforvinylenecarbonateandfluoroethylenecarbonateareexpectedtostartoperationinthesecondhalfoftheyear,improvingproductioncost−effectiveness[81].−TheGroupisactivelyinvestinginresearchanddevelopmentofhigh−value−addedchemicalproductstostrengthenitsproductportfolioandcompetitiveadvantages[80].ShareholderInformation−ThefinaldividendpaidduringtheperiodwasHK14centspershare,downfromHK17centspersharein2022,totalingHK115,500,000 compared to HK140,250,000inthepreviousyear[44].−Theinterimdividenddeclaredfor2024isHK14centspershare,anincreasefromHK5centspersharein2023,amountingtoHK115,500,000 compared to HK$41,250,000 in the previous year[44]. - As of June 30, 2024, Mr. Lee Man Yan holds 536,250,000 ordinary shares, representing 65% of the issued share capital of the Company[108]. - Ms. Wai Siu Kee holds 82,500,000 ordinary shares, representing 10% of the issued share capital of the Company[108]. Compliance and Governance - The Company has complied with the Corporate Governance Code throughout the six months ended June 30, 2024[115]. - All directors confirmed compliance with the Model Code for securities transactions during the reporting period[114]. - The Audit Committee reviewed the Group's results for the six months ended June 30, 2024, discussing accounting principles and internal controls[122].